🇺🇸 FDA
Pipeline program

Tacrolimus BID

0076-16 RMC

Phase 3 small_molecule active

Quick answer

Tacrolimus BID for Medication Adherence is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Medication Adherence
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials